HIGHGATE GROUP PRACTICE
44 NORTH HILL, HIGHGATE, LONDON
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 110 | 129 | 85.3% | |
| CKD 4 | 2008 | 118 | 138 | 85.5% | |
| CKD 5 | 2009 | 22 | 23 | 95.7% | |
| CKD 5 | 2010 | 9 | 10 | 90.0% | |
| CKD 5 | 2011 | 7 | 8 | 87.5% | |
| CKD 5 | 2012 | 5 | 6 | 83.3% | |
| CKD 5 | 2013 | 6 | 7 | 85.7% | |
| CKD003 | 2014 | 4 | 4 | 100.0% | |
| CKD003 | 2015 | 5 | 5 | 100.0% | |
| NM84 | 2016 | 3 | 6 | 50.0% | |
| NM84 | 2018 | 5 | 9 | 55.6% | |
| NM84 | 2019 | 13 | 17 | 76.5% | |
| NM84 | 2020 | 26 | 35 | 74.3% |
